High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma
Trial ID or NCT#
Status
Purpose
To evaluate the role of allogeneic hematopoietic cell transplantation in the treatment of NHL.
Official Title
High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin's Lymphoma
Eligibility Criteria
- Morphologically confirmed relapsed non-Hodgkin's lymphoma Age: >18 and <61 years of age Signed informed consent
- Hepatic dysfunction defined by serum transaminases >2.5X normal values Serum creatinine of > 2 mg/dl or creatinine clearance < 60 ml/min Diseases other than non-Hodgkin's lymphoma Prior bone marrow transplant procedure Severe psychological or medical illness
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
BMT Referrals
6507230822
View on ClinicalTrials.gov